Soluble Interleukin-1 Receptor Antagonist Serum Levels in Smokers and Nonsmokers with Graves’ Ophthalmopathy Undergoing Orbital Radiotherapy
1997
Interleukin-1 (IL-1) plays an important role in the pathogenesis of Graves’ ophthalmopathy (GO). Impaired antagonism of the proinflammatory cytokine IL-1 by the naturally occurring IL-1 receptor antagonist (IL-1RA) has been implicated in the initiation and perpetuation of various autoimmune diseases and may play a role in the evolution of GO. Cigarette smoking appears to adversely affect the course of GO. We have evaluated the course of IL-1α, IL-1β, and soluble IL-1RA (sIL-1RA) serum levels in smokers and nonsmokers with GO undergoing orbital radiotherapy (OR). We prospectively studied the eye status of 27 randomly selected patients (mean age 47.3 ± 11.0 yr; 20 females; 18 smokers) with active, moderately severe GO before and 3 and 6 months following OR, respectively. None had received any previous treatment for GO, and all patients were kept euthyroid on carbimazole. Serum concentrations of IL-1α, IL-1β, and sIL-1RA were measured using highly sensitive enzyme linked immunosorbent assay systems. Baseline...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
68
Citations
NaN
KQI